期刊文献+

甲状旁腺激素对成人成骨细胞护骨素和护骨素配体及其相关因子的调节

Effects of parathyroid hormone on osteoprotegerin expression and osteoprotegerin ligand and their related cytokines in human osteoblasts
下载PDF
导出
摘要 目的 :探讨甲状旁腺激素 (PTH)调节骨吸收作用的途径和机制。方法 :观察PTH对人成骨细胞(HOB)表达护骨素 (OPG)、护骨素配体 (OPGL)及其相关因子 ,如肿瘤坏死因子相关性凋亡诱导配体 (TRAIL)、巨噬细胞集落刺激因子 (M CSF)的影响 ,用RT PCR法检测OPG ,OPGL ,TRAIL及M CSF基因表达情况 ,用Westernblotting分析法检测OPG和OPGL蛋白表达情况。结果 :PTH下调HOB细胞中OPG的表达 ,上调OPGL ,M CSF及TRAIL的表达。结论 :PTH通过降低成骨细胞中OPG与OPGL的比值 ,增加M CSF和TRAIL的表达 ,促进破骨细胞生成、活化 。 Objective To investigate the pathway and mechanism of parathyroid hormone (PTH) in regulating bone resorption.Methods We observed the regulative effects of PTH on the expression of osteoprotegerin (OPG) and osteoprotegerin ligand (OPGL) and their related cytokines (M-CSF and TRAIL) in human osteoblasts (HOBs).The expressions of OPG,OPGL,M-CSF, and TRAIL mRNA were determined by RT-PCR. The expressions of OPG and OPGL proteins were measured by Western blotting. Results PTH down-regulated the expression of OPG but up-regulated the expressions of OPGL,M-CSF and TRAIL in HOBs.Conclusion PTH can promote the bone resorption by decreasing the expression of OPG ,increasing the expressions of some bone-resorbing cytokines such as OPGL, M-CSF, and TRAIL in osteoblasts,and then stimulating the osteoclast differentiation and activity.
出处 《中南大学学报(医学版)》 CAS CSCD 北大核心 2004年第5期562-565,共4页 Journal of Central South University :Medical Science
基金 国家自然科学基金 (39970 347)
关键词 OPG 护骨素 M-CSF PTH 表达 甲状旁腺激素 人成骨细胞 TRAIL 配体 RT-PCR法 parathyroid hormone human osteoblasts osteoprotegerin osteoprotegerin ligand
  • 相关文献

参考文献9

  • 1[1]Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density[J]. Cell, 1997,89(2):309-319. 被引量:1
  • 2[2]Takahashi N, Udagawa N ,Suda T. A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function[J]. Biochem Biophys Res Commun, 1999,256(3):449-455. 被引量:1
  • 3[3]Emery JG, McDonnell P, Burke MB, et al. Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL[J]. J Biol Chem, 1998,273(23):14363-14367. 被引量:1
  • 4[4]Horwood NJ,Elliott J,Martin JM,et al. Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells[J]. Endocrinology ,1998,139(11):4743-4746. 被引量:1
  • 5苏欣,廖二元,罗湘杭.人成骨细胞体外培养、鉴定及护骨素表达的研究[J].中国骨质疏松杂志,2002,8(4):283-286. 被引量:19
  • 6[6]Sumbrook J, Fritsch EF, Maniatis T. Molecular cloning:A laboratory manual[M]. 2nd ed. New York:Cold Spring Harbor Laboratory Press,1989.345-897. 被引量:1
  • 7[7]Qin L,Raggatt LJ,Partridge NC. Parathyroid hormone:a double-edged sword for bone metabolism[J]. Trends Endocrinol Metab,2004,15(2):60-65. 被引量:1
  • 8[8]Lee SK,Lorenzo JA. Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures correlation with osteoclast-like cell formation[J]. Endocrinology,1999,140(8): 3552-3561. 被引量:1
  • 9[9]Felix R, Cecchini MG , Fleisch H. Macrophage colony stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse[J]. Endocrinology, 1990,127(5):2592-2594. 被引量:1

二级参考文献7

  • 1[1]Simonet WS,Lacey DL,Dunstan CR,et al.Osteoprotegerin:a novel secreted protein involved in the regulation of bone density.Cell,1997,89:309-319. 被引量:1
  • 2[2]Toesca A,Pagnotta A,Specchia N.Evidence of type Ⅱ estrogen receptor in human osteoblast-like cells.Cell Biol Int,2000,24:303-309. 被引量:1
  • 3[3]Sumbrook J,et al.Molecular cloning laboratory manual.2nd ed.New York:Cold Spring Harbor Laboratory Press,1989,345-897. 被引量:1
  • 4[4]Bucay N,Sarosi I,Dunstan CR,et al.Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.Genes Dev,1998,12:1260-1268. 被引量:1
  • 5[5]Hofbauer LC,Dunstan CR,Spelsberg TC,et al.Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D,bone morphogenetic protein-2,and cytokines.Biochem Biophys Res Commun,1998,250:776-781. 被引量:1
  • 6[6]Howell A,Osborne CK,Morris C,et al.ICI182780(FaslodexTM),development of a novel,"pure"antiestrogen.Cancer,2000,89:817-825. 被引量:1
  • 7[7]Sibonga JD,Dobnig H,Harden RM,et al.Effect of the high-affinity estrogen receptor ligand ICI182780 on the rat tibia.Endocrinology,1998,139:3736-3742. 被引量:1

共引文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部